Model Guidance for the Storage and Transport of Time- and Temperature-Sensitive Pharmaceutical Products
The WHO model guidance (Technical Report Series No. 961, Annex 9, 2011) for storing and transporting time- and temperature-sensitive pharmaceutical products — the cold-chain qualification reference used worldwide, especially for vaccines and biologicals. It sets model requirements for temperature-controlled storage facilities and equipment, qualified transport routes and shipping containers, temperature monitoring and mapping, and the people and procedures that keep the chain intact, and is elaborated by a series of WHO Technical Supplements.
What this does not cover
stated in the document's own scope- Covers time- and temperature-sensitive pharmaceutical products; general pharmaceutical distribution practice is the subject of WHO GDP in TRS 957, Annex 5.
- Model guidance for adoption, not a binding instrument: national authorities and programmes give it force by incorporating it into their requirements.
- Addresses storage and transport infrastructure and operations; the stability data that define a product's permitted conditions come from the manufacturer's stability programme, not this guidance.
Always verify against the current published text before relying on it for a submission or inspection.
Overview
WHO's Model Guidance for the Storage and Transport of Time- and Temperature-Sensitive Pharmaceutical Products (Technical Report Series No. 961, Annex 9, 2011) is the international cold-chain reference. It sets model requirements for the infrastructure and operations that keep temperature-sensitive products — vaccines above all — within their labelled conditions: temperature-controlled storage facilities with qualified capacity, appropriate refrigeration equipment, temperature mapping of storage areas, qualified transport routes and shipping systems, temperature monitoring in storage and transit with alarm response, and the trained personnel and documented procedures that hold the chain together. A companion series of WHO Technical Supplements expands each requirement into implementable protocols.
Scope & applicability
Organisations storing or transporting time- and temperature-sensitive pharmaceutical products — national programmes, manufacturers, distributors, and logistics providers — in jurisdictions that reference WHO norms. General (non-TTSPP) distribution is covered by the WHO GDP guidance in TRS 957.
Legal basis & how it acquires force
An annex to the forty-fifth report of the WHO Expert Committee on Specifications for Pharmaceutical Preparations, published in WHO Technical Report Series No. 961 (2011). As model guidance it is written for national authorities and organisations to adopt: it binds where a regulator incorporates it into national requirements, and it functions as the reference standard in WHO-coordinated programmes and international vaccine procurement.
Document structure
| Part | Covers |
|---|---|
| Introduction, scope and glossary | The products and operations covered and the cold-chain terminology used throughout |
| Storage facilities | Model requirements for temperature-controlled storage, including qualification and temperature mapping of storage areas |
| Refrigeration equipment | Cold rooms, freezer rooms, refrigerators, and their maintenance |
| Transport and delivery | Route profiling, qualification of shipping containers and transport systems, and controls during transit |
| Temperature monitoring and personnel | Monitoring and alarm requirements in storage and transport, and the training and procedures supporting them |
Key requirements
- Temperature-controlled storage capacity qualified and mapped, with alarmed monitoring
- Refrigeration equipment appropriate to the products and maintained
- Transport routes profiled and shipping systems qualified for the lanes they serve
- Continuous or risk-appropriate temperature monitoring in storage and transit, with alarm response
- Trained personnel and documented procedures across the cold chain
Implementation tips
- Use the companion WHO Technical Supplements as the how-to layer — they turn each model requirement (mapping, lane qualification, monitoring) into an implementable protocol
Revision notes
Issued in WHO TRS 961 (2011); a set of WHO Technical Supplements (2015) expands its qualification and monitoring requirements into detailed implementation guidance.
Where this control fails
live FDA enforcementLive FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
International alignment
The model guidance extends the WHO GDP framework (TRS 957, Annex 5) into the time- and temperature-sensitive domain, and its qualification philosophy — map, qualify, monitor — parallels the EU GDP guidelines' temperature-management expectations, USP <1079>'s risk-based storage and transportation chapter, and the industry methodology of PDA Technical Report No. 39. The WHO Technical Supplements published in 2015 carry its requirements into step-by-step implementation guidance.
WHO TRS 961, Annex 9: frequently asked questions
Quick answers to common questions about WHO TRS 961, Annex 9.
What products does WHO TRS 961 Annex 9 cover?
Time- and temperature-sensitive pharmaceutical products — products whose quality degrades outside defined temperature limits, with vaccines and biologicals as the archetypal cases. General distribution of pharmaceuticals is covered by WHO GDP instead.
What are the WHO Technical Supplements to Annex 9?
A series of companion documents, issued in 2015, that turn the model guidance's requirements into detailed implementation protocols — temperature mapping of storage areas, qualification of shipping containers, monitoring system selection, and related topics.
Is the model guidance mandatory?
Not by itself. It is model guidance written for adoption: it becomes enforceable where a national regulator incorporates it into distribution or licensing requirements, and it operates as the de facto standard in international vaccine supply chains coordinated through WHO and UN procurement.
This standard in practice
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.